Stories

Firas Abdul-Hadi, international regional manager for the Middle East and North Africa region, connects health care providers with Mayo Clinic Laboratories, so their patients can benefit from the most advanced, highest quality laboratory testing in the world.

This week’s research roundup features: Phase II randomized trial of transoral surgery and low-dose intensity Modulated radiation therapy in resectable p16+ locally advanced oropharynx cancer: An ECOG-ACRIN cancer research group trial (E3311).

Advanced testing at Mayo Clinic Laboratories that confirmed a diagnosis of myasthenia gravis put Lorinda McKinley on the road to renewed health after she nearly lost it all to the rare autoimmune disease.

Topic's Include: Mayo Clinic Q&A podcast: Understanding mix-and-match COVID-19 boosters, Emergency use authorization for COVID-19 vaccines, and what to know now to plan for a safe Thanksgiving gathering.

This week’s research roundup features: Proceedings from the ice hockey summit III: Action on concussion.

Topic's Include: Mayo Clinic to offer walk-in COVID-19 vaccination clinics in Rochester, Mayo Clinic Minute: high- vs. low-risk Halloween ideas, and Covid Queries: Do I need the vaccine if I’ve had COVID-19?

Cynthia Collie, a hospital account executive for Mayo Clinic Laboratories, focuses on connecting her clients with the right people, tools, and services to meet their needs and goals.

This week’s research roundup features: Autopsy validation of progressive supranuclear palsy-predominant speech/language disorder criteria.

In part three of the 50th Anniversary series, Mayo Clinic Laboratories looks further outside the walls of Mayo Clinic. With the belief that the latest in diagnostic testing should be available to any patient, no matter where they are located, the sales force was born.

Topic's Include: Covid Queries: Altered DNA and microchips, Mayo Clinic Minute: Flu during a pandemic, and COVID-19 media only news briefing: Kids, COVID-19 and fall festivities / tips for staying safe.

In a newly published study, a team from Mayo Clinic’s Advanced Diagnostics Laboratory has developed a mass spectrometry-based assay that’s able to detect COVID-19 (SARS-CoV-2) pathogens from human proteins with, remarkably, 98% sensitivity and 100% specificity. This is the first assay of its kind that can detect viral antigens “directly from clinical specimens” such as nasopharyngeal swabs. Mass spectrometry is a sensitive technique used to detect, identify, and quantitate molecules present in a sample.   

This week’s research roundup features: Effect of urate-elevating inosine on early Parkinson disease progression: The SURE-PD3 randomized clinical trial.

Topic's Include: COVID-19 media only news briefing: What we know so far about post-COVID syndrome, Mayo Clinic Q&A podcast: The case for continuing COVID-19 precautions, and COVID queries: The speed of vaccine development.